Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Sponsors and Collaborators
Cancer and Leukemia Group B
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
NCIC Clinical Trials Group
James A. Eastham, MD, Memorial Sloan-Kettering Cancer Center
Martin G. Sanda, MD, Beth Israel Deaconess Medical Center
Martin E. Gleave, MD, Vancouver General Hospital
Next post in Prostate Cancer Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.